The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1079857
WO Application Number:
US1999011977
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP99926046.6
WO Publication Number:
WO1999061053
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
28/05/1999
Grant date:
29/11/2006
EP Publication Date:
29/11/2006
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/06/2018
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
29/11/2006
EP B1 Publication Date:
29/11/2006
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/05/2019
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
03/05/2017
Name:
The Norwegian Institute of Public Health
Address:
P O Box 4404, 0403 Oslo, Norway (NO)
From:
03/05/2017
Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Historical Applicant/holder
From:
01/05/2007
To:
03/05/2017
Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)
From:
01/05/2007
To:
03/05/2017
Name:
The Norwegian Institute of Public Health
Address:
P O Box 4404, 0403 Oslo, Norway (NO)
From:
29/11/2006
To:
01/05/2007
Name:
Novartis Vaccines and Diagnostics, Inc.
Address:
4560 Horton Street, 94608-2916, Emeryville, California, United States of America (US)